# Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots

> **NCT02768441** · EARLY_PHASE1 · COMPLETED · sponsor: **The Netherlands Cancer Institute** · enrollment: 12 (actual)

## Conditions studied

- Cocaine Addiction

## Interventions

- **DRUG:** Dexamphetamine

## Key facts

- **NCT ID:** NCT02768441
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-01
- **Primary completion:** 2017-06-01
- **Final completion:** 2017-06-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02768441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02768441, "Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02768441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*